COVIDIEN is distributing blood
pressure monitors that measure
blood pressure and atrial fibrillation
(AF) simultaneously.
The device was not a diagnostic
tool but could be used for
“opportunistic screening”, to
identify those with undiagnosed AF,
the company said.
The Microlife AFIB home
monitoring models include the
pharmacy exclusive ‘Microlife
A200AFIB’ with an RRP of $190, or
the ‘Microlife Watch BP Home A’
for an RRP of $325.
Pharmacies that purchased six
units will receive a free trial unit for
in-store screening.
The Watch BP Home A was
recommended by the UK’s
National Institute for Health and
Care Excellence, with Centre for
Health Technology Evaluation
director Professor Carole Longson
saying evidence indicated the
device would offer advantages in
detecting AF opportunistically while
measuring blood pressure.The above article was sent to subscribers in Pharmacy Daily's issue from 01 May 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 May 14
THOUGH women make up 60% of pharmacy graduates and pharmacists, they hold only 34% of leadership and ownership roles, according to Andria Aird, a community pharmacist, pharmacy owner, and Board Director of Blooms The Chemist.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.